CDH2 and benign prostatic hyperplasia: The relative expression of N-cadherin, NDRG1, and AR was evaluated in prostate hyperplasia (BPH-1), androgen-dependent PCa (ADPC) (LNCaP), and CRPC (PC3) cell lines.